| Trial ID: | L0972 |
| Source ID: | NCT00816465
|
| Associated Drug: |
Hoodia gordonii
|
| Title: |
Safety and Efficacy of Hoodia Gordonii for Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-Alcoholic Fatty Liver Disease
|
| Interventions: |
Dietary Supplement: Hoodia gordonii;Other: Placebo
|
| Outcome Measures: |
decreased insulin resistance;safetyreduced hepatic injury;reduced weight/BMI/abdominal circumference
|
| Sponsor/Collaborators: |
Hadassah Medical Organization
|
| Gender: |
All
|
| Age: |
18 Years65 Years
|
| Phases: |
Phase 1
|
| Enrollment: |
20
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
|
| Start Date: |
31/12/2008
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
19 February 2015
|
| Locations: |
Israel
|
| URL: |
http://clinicaltrials.gov/show/NCT00816465
|